{
  "pmcid": "6282568",
  "sha256": "74db99df089ab6744b72268afbf8acab6daa34e41c3b26b417f4b45b5fe41174",
  "timestamp_utc": "2025-11-10T00:01:04.186402+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.91800829875519,
    "reading_ease": 28.296469837216733,
    "word_count": 241
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of High-Flow Nasal Oxygen in High-Risk Cardiac Surgical Patients"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "100 adult patients scheduled for elective cardiac surgery were randomised 1:1"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included COPD, asthma, recent lower respiratory tract infection, BMI ≥35 kg/m², or heavy smoking."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 1:1 to receive HFNO (n=51) or standard oxygen therapy (n=49)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study assessed the efficacy of high-flow nasal oxygen (HFNO) in reducing hospital length of stay compared to standard oxygen therapy"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was hospital length of stay, measured from surgery to discharge."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence with allocation concealment via a centralised online system."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Surgical and nursing teams responsible for discharge were blinded to group allocation."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "100 adult patients scheduled for elective cardiac surgery were randomised 1:1"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "randomised 1:1 to receive HFNO (n=51) or standard oxygen therapy (n=49)"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The geometric mean hospital stay was 29% lower in the HFNO group (95% CI 11–44%, p=0.004)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported in either group."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}